We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals
ACAD

297 hedge funds and large institutions have $7.4B invested in Acadia Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 80 increasing their positions, 95 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 26

21% more funds holding

Funds holding: 246 → 297 (+51)

14% more capital invested

Capital invested by funds: $6.51B → $7.4B (+$890M)

1.23% less ownership

Funds ownership: 99.26% → 98.03% (-1.2%)

14% less call options, than puts

Call options by funds: $39.2M | Put options by funds: $45.6M

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

16% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 95

Holders
297
Holders Change
+51
Holders Change %
+20.73%
% of All Funds
6.09%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.12%
New
79
Increased
80
Reduced
95
Closed
26
Calls
$39.2M
Puts
$45.6M
Net Calls
-$6.47M
Net Calls Change
-$6.04M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$116M
2
JIM
Jupiter Investment Management
United Kingdom
+$43.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$41.2M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$30M
5
Ameriprise
Ameriprise
Minnesota
+$27.6M

Top Sellers

1
BlackRock
BlackRock
New York
-$114M
2
State Street
State Street
Massachusetts
-$70.8M
3
HM
HealthCor Management
New York
-$57.9M
4
EAM
Eagle Asset Management
Florida
-$46M
5
Northern Trust
Northern Trust
Illinois
-$42.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
101
Bank of Montreal
Ontario, Canada
$4.29M -$402K -8,380 -10%
State of New Jersey Common Pension Fund D
102
State of New Jersey Common Pension Fund D
New Jersey
$4.16M +$293K +6,094 +8%
LCG
103
Lisanti Capital Growth
New York
$3.94M -$330K -6,868 -8%
SFI
104
Susquehanna Fundamental Investments
Pennsylvania
$3.81M +$3.77M +78,600 New
Los Angeles Capital Management
105
Los Angeles Capital Management
California
$3.77M +$594K +12,374 +19%
PI
106
Putnam Investments
Massachusetts
$3.63M +$246K +5,132 +7%
MOACM
107
Mutual of America Capital Management
New York
$3.48M -$1.51M -31,370 -30%
WCM Investment Management
108
WCM Investment Management
California
$3.38M -$1.34M -27,891 -29%
Squarepoint
109
Squarepoint
New York
$3.21M -$634K -13,197 -17%
QI
110
QS Investors
New York
$3.02M -$2.4K -50 -0.1%
WP
111
Woodline Partners
California
$2.98M +$2.96M +61,575 New
EAM
112
Eagle Asset Management
Florida
$2.89M -$46M -957,556 -94%
Sumitomo Mitsui Trust Group
113
Sumitomo Mitsui Trust Group
Japan
$2.8M +$2.77M +57,740 New
Principal Financial Group
114
Principal Financial Group
Iowa
$2.74M -$437K -9,099 -14%
CAM
115
ClariVest Asset Management
California
$2.74M -$3.1M -64,581 -53%
Russell Investments Group
116
Russell Investments Group
United Kingdom
$2.61M -$3.69M -76,938 -59%
CM
117
Caption Management
Oklahoma
$2.45M +$2.42M +50,457 New
DIM
118
Delta Investment Management
California
$2.32M +$2.3M +47,933 New
Aviva
119
Aviva
United Kingdom
$2.3M +$2.28M +47,422 New
MAP
120
Moody Aldrich Partners
Massachusetts
$2.28M -$3.51M -73,181 -61%
VOYA Investment Management
121
VOYA Investment Management
Georgia
$2.27M -$655K -13,638 -23%
TMAM
122
Tokio Marine Asset Management
Japan
$2.23M +$24K +500 +1%
IC
123
Ikarian Capital
Texas
$2.23M +$2.21M +46,008 New
BG
124
Bellevue Group
Switzerland
$2.18M +$139K +2,900 +7%
Ohio Public Employees Retirement System (OPERS)
125
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.02M +$2M +41,713 New
3 4
5
6 7

ACAD Hedge Fund Activity: Q2 2020 in Review

297 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Acadia Pharmaceuticals (ACAD) for Q2 2020, worth a combined $7.4B — up 14% from $6.51B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new ACAD positions and 26 closed out — a net gain of 53 holders — while 80 added to existing stakes and 95 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $116M. The largest seller was BlackRock, cutting an estimated $114M.

  • 297 institutional investors held Acadia Pharmaceuticals (ACAD) as of Q2 2020, up from 246 in Q1 2020.
  • Funds reported $7.4B of Acadia Pharmaceuticals stock for Q2 2020, up 14% quarter-over-quarter.
  • 79 funds opened new Acadia Pharmaceuticals positions in Q2 2020 and 26 closed out, a net change of +53 holders.
  • The largest Acadia Pharmaceuticals buyer in Q2 2020 was Janus Henderson Group, an estimated $116M added.
  • The largest Acadia Pharmaceuticals seller in Q2 2020 was BlackRock, an estimated $114M sold.

Based on aggregated 13F filings for Q2 2020.